Cytokine response of cultured skeletal muscle cells stimulated with proinflammatory factors depends on differentiation stage

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Podbregar, Matej ^a   Lainscak, Mitja ^b,c   Prelovsek, Oja ^d   Mars, Tomaz ^d  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; IL6 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MYOBLAST; SKELETAL MUSCLE; UPREGULATION; CELL CULTURE; CELL DEATH; CYTOLOGY; DRUG EFFECT; INFLAMMATION; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

CELL DEATH; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874843997     PISSN: 1537744X     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/617170     Document Type: Article

References (49)

1. Cruz-Jentoft A. J., Landi F., Topinková E., Michel J. P., Understanding sarcopenia as a geriatric syndrome. Current Opinion in Clinical Nutrition and Metabolic Care 2010 13 1 1 7 2-s2.0-73849138837 10.1097/MCO.0b013e328333c1c1
2. Tisdale M. J., Cancer cachexia. Current Opinion in Gastroenterology 2010 26 2 146 151 2-s2.0-77149130208 10.1097/MOG.0b013e3283347e77
3. von Haehling S., Anker S. D., Cachexia as a major underestimated and unmet medical need: facts and numbers. Journal of Cachexia, Sarcopenia and Muscle 2010 1 1 5
4. Lenk K., Schuler G., Adams V., Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. Journal of Cachexia, Sarcopenia and Muscle 2010 1 9 21
5. Ciciliot S., Schiaffino S., Regeneration of mammalian skeletal muscle: basic mechanisms and clinical implications. Current Pharmaceutical Design 2010 16 8 906 914 2-s2.0-77950238226 10.2174/138161210790883453
6. Chargé S. B. P., Rudnicki M. A., Cellular and molecular regulation of muscle regeneration. Physiological Reviews 2004 84 1 209 238 2-s2.0-0347989458 10.1152/physrev.00019.2003 (Pubitemid 38049880)
7. Tidball J. G., Villalta S. A., Regulatory interactions between muscle and the immune system during muscle regeneration. American Journal of Physiology 2010 298 5 R1173 R1187 2-s2.0-77951700255 10.1152/ajpregu.00735.2009
8. Serrano A. L., Baeza-Raja B., Perdiguero E., Jardí M., Muñoz-Cánoves P., Interleukin-6 is an essential regulator of satellite-cell-mediated skeletal muscle hypertrophy. Cell Metabolism 2008 7 33 44
9. Bruusgaard J. C., Johansen I. B., Egner I. M., Rana Z. A., Gundersen K., Myonuclei acquired by overload exercise precede hypertrophy and are not lost on detraining. Proceedings of the National Academy of Sciences of the United States of America 2010 107 34 15111 15116 2-s2.0-77956996905 10.1073/pnas.0913935107
10. Pannérec A., Marazzi G., Sassoon D., Stem cells in the hood: the skeletal muscle niche. Trends in Molecular Medicine 2012 18 599 606
11. Pedersen B. K., Febbraio M. A., Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiological Reviews 2008 88 4 1379 1406 2-s2.0-55949119252 10.1152/physrev.90100.2007
12. Puppa M. J., White J. P., Velázquez K. T., Baltgalvis K. A., Sato S., Baynes J. W., Carson J. A., The effect of exercise on IL-6-induced cachexia in the Apc (Min/+) mouse. Journal of Cachexia, Sarcopenia and Muscle 2012 3 117 137
13. Kami K., Senba E., Localization of leukemia inhibitory factor and interleukin-6 messenger ribonucleic acids in regenerating rat skeletal muscle. Muscle & Nerve 1998 21 819 822 (Pubitemid 28248693)
14. Kurek J. B., Nouri S., Kannourakis G., Murphy M., Austin L., Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle & Nerve 1996 19 1291 1301 (Pubitemid 26313826)
15. Prelovsek O., Mars T., Jevsek M., Podbregar M., Grubic Z., High dexamethasone concentration prevents stimulatory effects of TNF- α and LPS on IL-6 secretion from the precursors of human muscle regeneration. American Journal of Physiology 2006 291 6 R1651 R1656 2-s2.0-33845425133 10.1152/ajpregu.00020.2006 (Pubitemid 44904131)
16. De Rossi M., Bernasconi P., Baggi F., De Waal Malefyt R., Mantegazza R., Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. International Immunology 2000 12 9 1329 1335 2-s2.0-0033842592 (Pubitemid 30657777)
17. Austin L., Bower J., Kurek J., Vakakis N., Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. Journal of the Neurological Sciences 1992 112 1-2 185 191 2-s2.0-0026470466 10.1016/0022-510X(92)90149-F
18. Al-Khalili L., Bouzakri K., Glund S., Lönnqvist F., Koistinen H. A., Krook A., Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Molecular Endocrinology 2006 20 12 3364 3375 2-s2.0-33751501694 10.1210/me.2005-0490 (Pubitemid 44833576)
19. Baeza-Raja B., Muñoz-Cánoves P., p38 MAPK-induced nuclear factor- B activity is required for skeletal muscle differentiation: role of interleukin-6. Molecular Biology of the Cell 2004 15 4 2013 2026 2-s2.0-1642423481 10.1091/mbc.E03-08-0585 (Pubitemid 38401847)
20. Cooney R. N., Maish G. O., Gilpin T., Shumate M. L., Lang C. H., Vary T. C., Mechanism of IL-1 induced inhibition of protein synthesis in skeletal muscle. Shock 1999 11 4 235 241 2-s2.0-0033111185
21. Lang C. H., Frost R. A., Nairn A. C., MacLean D. A., Vary T. C., TNF- α impairs heart and skeletal muscle protein synthesis by altering translation initiation. American Journal of Physiology 2002 282 2 E336 E347 2-s2.0-0036087765 (Pubitemid 34654804)
22. Pedersen B. K., The diseasome of physical inactivity-and the role of myokines in muscle-fat cross talk. Journal of Physiology 2009 587 23 5559 5568 2-s2.0-71249157791 10.1113/jphysiol.2009.179515
23. Hirata A., Masuda S., Tamura T., Kai K., Ojima K., Fukase A., Motoyoshi K., Kamakura K., Miyagoe-Suzuki Y., Takeda S., Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. American Journal of Pathology 2003 163 1 203 215 2-s2.0-0037969777 (Pubitemid 36759605)
24. Pimorady-Esfahani A., Grounds M. D., McMenamin P. G., Macrophages and dendritic cells in normal and regenerating murine skeletal muscle. Muscle & Nerve 1997 20 158 166 (Pubitemid 27061527)
25. Arnold L., Henry A., Poron F., Baba-Amer Y., Van Rooijen N., Plonquet A., Gherardi R. K., Chazaud B., Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. Journal of Experimental Medicine 2007 204 5 1057 1069 2-s2.0-34248997759 10.1084/jem.20070075 (Pubitemid 46798150)
26. Borge B. A. S., Kalland K. H., Olsen S., Bletsa A., Berggreen E., Wiig H., Cytokines are produced locally by myocytes in rat skeletal muscle during endotoxemia. American Journal of Physiology 2009 296 3 H735 H744 2-s2.0-64049095100 10.1152/ajpheart.01309.2008
27. Lang C. H., Silvis C., Deshpande N., Nystrom G., Frost R. A., Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock 2003 19 6 538 546 2-s2.0-0142064412
28. Luo G., Hershko D. D., Robb B. W., Wray C. J., Hasselgren P. O., IL-1 β stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF- B. American Journal of Physiology 2003 284 5 R1249 R1254 2-s2.0-18244421931 (Pubitemid 36457567)
29. Langen R. C. J., Van Der Velden J. L. J., Schols A. M. W. J., Kelders M. C. J. M., Wouters E. F. M., Janssen-Heininger Y. M. W., Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. The FASEB Journal 2004 18 2 227 237 2-s2.0-0442324933 10.1096/fj.03-0251com (Pubitemid 38186242)
30. Li Y. P., TNF- α is a mitogen in skeletal muscle. American Journal of Physiology 2003 285 2 C370 C376 2-s2.0-0042242879
31. Grubic Z., Komel R., Walker W. F., Miranda A. F., Myoblast fusion and innervation with rat motor nerve alter distribution of acetylcholinesterase and its mRNA in cultures of human muscle. Neuron 1995 14 2 317 327 2-s2.0-0028848044
32. Marš T., Effects of LIF on neuromuscular junction formation in co-cultures of rat spinal cord explant and human muscle. Croatica Chemica Acta 2008 81 1 177 182 2-s2.0-47849110336
33. Pirkmajer S., Filipovic D., Mars T., Mis K., Grubic Z., HIF-1 α response to hypoxia is functionally separated from the glucocorticoid stress response in the in vitro regenerating human skeletal muscle. American Journal of Physiology 2010 299 6 R1693 R1700 2-s2.0-78649851593 10.1152/ajpregu.00133.2010
34. Golicnik A., Podbregar M., Lainscak M., Anker S. D., Grubic Z., Mars T., Atorvastatin modulates constitutive and lipopolysaccharide induced IL-6 secretion in precursors of human skeletal muscle. African Journal of Pharmacy and Pharmacology 2012 6 241 247
35. Broussard S. R., McCusker R. H., Novakofski J. E., Strle K., Shen W. H., Johnson R. W., Dantzer R., Kelley K. W., IL-1 β impairs insulin-like growth factor I-induced differentiation and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Journal of Immunology 2004 172 12 7713 7720 2-s2.0-2942555110 (Pubitemid 38747638)
36. Carbó N., Busquets S., Van Royen M., Alvarez B., López-Soriano F. J., Argilés J. M., TNF- α is involved in activating DNA fragmentation in skeletal muscle. British Journal of Cancer 2002 86 6 1012 1016 2-s2.0-0037128669 10.1038/sj.bjc.6600167 (Pubitemid 34271042)
37. Li Y. P., Schwartz R. J., TNF-alpha regulates early differentiation of C2C12 myoblasts in an autocrine fashion. The FASEB Journal 2001 15 8 1413 1415 2-s2.0-0035375064
38. Pedersen B. K., Brandt C., The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. Journal of Biomedicine and Biotechnology 2010 2010 6 2-s2.0-77951685571 10.1155/2010/520258 520258
39. Bartoccioni E., Michaelis D., Hohlfeld R., Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunology Letters 1994 42 3 135 138 2-s2.0-0027946220 10.1016/0165-2478(94)90076-0 (Pubitemid 24378122)
40. Hauschka S. D., Emerson C. P., Engel A. G., Franzini-Armstrong C., Embryonic origins of skeletal muscles. Myology 2004 1 New York, NY, USA McGraw-Hill 3 44
41. Askanas V., Kwan H., Alvarez R. B., Engel W. K., Kobayshi T., Martinuzzi A., Hawkins E. F., De novo neuromuscular junction formation on human muscle fibres cultured in monolayer and innervated by foetal rat spinal cord: ultrastructural and ultrastructural-cytochemical studies. Journal of Neurocytology 1987 16 4 523 537 2-s2.0-0023261258 (Pubitemid 17140507)
42. Alvarez B., Quinn L. S., Busquets S., López-Soriano F. J., Argilés J. M., TNF- α modulates cytokine and cytokine receptors in C2C12 myotubes. Cancer Letters 2002 175 2 181 185 2-s2.0-0037168951 10.1016/S0304-3835(01)00717-0 (Pubitemid 34001716)
43. Frost R. A., Nystrom G. J., Lang C. H., Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes. American Journal of Physiology 2006 290 3 R773 R784 2-s2.0-33645390632 10.1152/ajpregu.00490.2005
44. Bakkar N., Guttridge D. C., NF- B signaling: a tale of two pathways in skeletal myogenesis. Physiological Reviews 2010 90 2 495 511 2-s2.0-77951089274 10.1152/physrev.00040.2009
45. Figarella-Branger D., Civatte M., Bartoli C., Pellissier J. F., Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle and Nerve 2003 28 6 659 682 2-s2.0-0344875464 10.1002/mus.10462 (Pubitemid 37484828)
46. Szalay K., Rázga Z., Duda E., TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. European Journal of Cell Biology 1997 74 4 391 398 2-s2.0-1842293386 (Pubitemid 27517312)
47. Guttridge D. C., Mayo M. W., Madrid L. V., Wang C. Y., Baldwin A. S., NF- B-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000 289 5488 2363 2365 2-s2.0-0034730251 10.1126/science.289. 5488.2363
48. Moresi V., Pristerà A., Scicchitano B. M., Molinaro M., Teodori L., Sassoon D., Adamo S., Coletti D., Tumor necrosis factor- α inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response. Stem Cells 2008 26 4 997 1008 2-s2.0-49249107691 10.1634/stemcells. 2007-0493
49. Arend W. P., Palmer G., Gabay C., IL-1, IL-18, and IL-33 families of cytokines. Immunological Reviews 2008 223 1 20 38 2-s2.0-47249089097 10.1111/j.1600-065X.2008.00624.x (Pubitemid 351986169)